<ul data-eligibleForWebStory="true">Netherlands-based AIKON Health secures €1.2M in seed funding led by TTT Medtech fund for remote heart failure monitoring technology.Funding round includes participation from BOM, BSF, RIL, and TNO Ventures.AIKON Health's wearable for heart failure monitoring receives support for its clinical relevance from investors.The company aims to shift heart failure care from hospital to home with its wearable device.Heart failure affects over 15 million Europeans with monitoring challenges, leading to avoidable costs.AIKON's technology allows continuous monitoring of patients' health indicators from home to enable remote clinical decision-making.The wearable device uses TNO's expertise in printed and flexible electronics for remote patient monitoring.AIKON Health focuses on achieving FDA approval for its technology to enter European and American healthcare markets.Funds will support product development and clinical validation towards FDA approval.The company targets reducing heart failure patients' hospital readmissions by 25% through its modular wearable solution.AIKON Health is part of TNO Ventures' efforts to commercialize breakthrough technologies and strengthen the Dutch innovation ecosystem.